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Purpose
Pediatric Systemic Lupus Erythematosus (pSLE) is a mult-
isystem, inflammatory, autoimmune disease. This study is
based on the observation that there are limited data on
the prognostic factors of children affected by SLE and
weak data correlating the course of the disease with its
onset. The primary aim of this study is to assess if atypical
onset influence the severity of organ damage in pSLE.
Methods
This is a multicenter IRB-approved chart review. We
enrolled all patients affected by pSLE. Medical records
were reviewed focusing on clinical features at onset,
intended as date of diagnosis and the following 15 days.
As atypical onset we meant organ involvement present at
onset of pediatric SLE described in literature http://
www.pubmed.com/index, but not included in ACR crite-
ria. The primary outcome was established to be the pres-
ence of at least 1 score of System Lupus International
Collaborating Clinics/American College of Rheumatology
Damage Index for Systemic Lupus Erythematosus (SLICC/
ACR). Data on 100 patients were analyzed with multivar-
iate analysis.
Results
Our population consisted in: 68 Caucasians, 24 Afro-
Americans, 5 Latin-Americans and 2 Asians. There were 79
females and 21 males. They were followed up for an aver-
age of 5.3 years. 24% of patients presented aypical clinical
features at onset. At multivariate analysis a significant
association with outcome variables was showed for the
presence at onset of atypical manifestations (p = 0.004)
and renal involvement (p = 0.027).
Conclusion
Our data suggest that the presence of renal involvement
and atypical manifestations at onset influence the progno-
sis of patients affected from pSLE.
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